Drug profile · INN
ombitasvir hydrate/paritaprevir hydrate/ritonavir
VIEKIRAX INITIAL APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
ombitasvir hydrate/paritaprevir hydrate/ritonavir (VIEKIRAX INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN ombitasvir hydrate/paritaprevir hydrate/ritonavir
Brand VIEKIRAX INITIAL APPROVAL
Frequently asked questions
What is ombitasvir hydrate/paritaprevir hydrate/ritonavir?
ombitasvir hydrate/paritaprevir hydrate/ritonavir (VIEKIRAX INITIAL APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for ombitasvir hydrate/paritaprevir hydrate/ritonavir?
VIEKIRAX INITIAL APPROVAL is a marketed brand name for ombitasvir hydrate/paritaprevir hydrate/ritonavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.